Nurix Therapeutics (NRIX)
(Delayed Data from NSDQ)
$24.10 USD
-1.52 (-5.93%)
Updated Sep 23, 2024 04:00 PM ET
3-Hold of 5 3
F Value B Growth A Momentum C VGM
Nurix Therapeutics, Inc. (NRIX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$28.46 | $36.00 | $15.00 | 18.09% |
Price Target
Based on short-term price targets offered by 13 analysts, the average price target for Nurix Therapeutics, Inc. comes to $28.46. The forecasts range from a low of $15.00 to a high of $36.00. The average price target represents an increase of 18.09% from the last closing price of $24.10.
Analyst Price Targets (13)
Broker Rating
Nurix Therapeutics, Inc. currently has an average brokerage recommendation (ABR) of 1.31 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms. The current ABR compares to an ABR of 1.31 a month ago based on 13 recommendations.
Of the 13 recommendations deriving the current ABR, 10 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 76.92% and 15.38% of all recommendations. A month ago, Strong Buy made up 76.92%, while Buy represented 15.38%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 10 | 10 | 9 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.31 | 1.31 | 1.31 | 1.31 | 1.33 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/6/2024 | Robert W. Baird & Co. | Joel L Beatty | Strong Buy | Strong Buy |
9/4/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
7/31/2024 | Truist Securities | Srikripa Devarakonda | Not Available | Strong Buy |
7/12/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
6/18/2024 | H.C. Wainwright & Co. | Robert Burns | Strong Buy | Strong Buy |
6/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
6/17/2024 | Needham & Company | Gil J Blum | Moderate Buy | Moderate Buy |
5/15/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
5/14/2024 | Stephens | Sudan Loganathan | Not Available | Strong Buy |
4/17/2024 | Piper Sandler | Joseph M Catanzaro | Strong Buy | Strong Buy |
2/16/2024 | Wells Fargo Securities | Derek C Archila | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.31 |
ABR (Last week) | 1.31 |
# of Recs in ABR | 13 |
Average Target Price | $28.46 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 80 of 253 |
Current Quarter EPS Est: | -0.67 |
NRIX FAQs
Nurix Therapeutics, Inc. (NRIX) currently has an average brokerage recommendation (ABR) of 1.31 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 13 brokerage firms.
The average price target for Nurix Therapeutics, Inc. (NRIX) is $28.46. The current on short-term price targets is based on 7 reports.
The forecasts for Nurix Therapeutics, Inc. (NRIX) range from a low of $15 to a high of $36. The average price target represents a increase of $18.09 from the last closing price of $24.10.
The current UPSIDE for Nurix Therapeutics, Inc. (NRIX) is 18.09%
Based on short-term price targets offered by 13 analysts, the average price target for Nurix Therapeutics, Inc. comes to $28.46. The forecasts range from a low of $15.00 to a high of $36.00. The average price target represents an increase of 18.09% from the last closing price of $24.10.